Helkha Peredo-Pinto

Hematology | Oncology
3800 Reservoir Rd NW
Washington, DC 20007

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

FDA Approval Summary: Lisocabtagene Maraleucel for Second-Line Treatment of Large B-Cell Lymphoma.

FDA Approval Summary: Lisocabtagene Maraleucel for Second-Line Treatment of Large B-Cell Lymphoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 11, 2023
Showing 1-1 of 1

Last Updated: 09/26/2026